Hsbc Holdings PLC Buys 9,367 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Posted by Defense World Staff on Feb 26th, 2023

Hsbc Holdings PLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 7.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 138,628 shares of the medical instruments supplier’s stock after buying an additional 9,367 shares during the period. Hsbc Holdings PLC owned 0.06% of DENTSPLY SIRONA worth $4,014,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Wipfli Financial Advisors LLC bought a new position in DENTSPLY SIRONA during the third quarter valued at about $27,000. Riverview Trust Co raised its holdings in DENTSPLY SIRONA by 185.6% during the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 644 shares in the last quarter. SRS Capital Advisors Inc. bought a new position in shares of DENTSPLY SIRONA in the third quarter worth about $28,000. Ellevest Inc. increased its stake in shares of DENTSPLY SIRONA by 281.2% in the third quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 897 shares during the period. Finally, SJS Investment Consulting Inc. bought a new position in shares of DENTSPLY SIRONA in the third quarter worth about $35,000. 98.52% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Down 2.5 %

NASDAQ XRAY opened at $34.33 on Friday. The company has a current ratio of 1.50, a quick ratio of 1.04 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average is $35.12 and its two-hundred day moving average is $32.56. The company has a market capitalization of $7.38 billion, a price-to-earnings ratio of 12.86, a PEG ratio of 4.68 and a beta of 0.94. DENTSPLY SIRONA Inc. has a 1-year low of $26.48 and a 1-year high of $58.70.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend was Thursday, December 29th.

Analyst Ratings Changes

A number of research firms have recently commented on XRAY. Evercore ISI lifted their price objective on DENTSPLY SIRONA to $34.00 in a research note on Thursday, November 17th. William Blair upgraded DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research note on Wednesday, January 11th. Morgan Stanley dropped their price objective on DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 15th. Piper Sandler lifted their price objective on DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, February 6th. Finally, TheStreet downgraded DENTSPLY SIRONA from a “c” rating to a “d” rating in a research report on Monday, November 14th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $41.30.

DENTSPLY SIRONA Company Profile

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.